Home › NDC Lookup › Ingredients › Furosemide › 73542-0102-25
Furosemide 10 mg/mL Injection — NDC 73542-0102-25 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Furosemide 10 mg/mL Injection — NDC 73542-102-25 (Billing 73542-0102-25)

by Maiva Pharma Private Limited · 25 VIAL in 1 CARTON / 4 mL in 1 VIAL

This is a package of Furosemide 10 mg/mL Injection from Maiva Pharma Private Limited, marketed since Jun 2025 and currently FDA-listed. It is this product's only package size.

NDC 73542-0102-25
🏷️ FDA NDC (as labeled) 73542-102-25 billing pads the product segment with a zero
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Furosemide (different manufacturers) — 2 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Mar 20, 2026 — CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit. (Leading Pharma, LLC) · FDA recall D-0486-2026
Class II · Jan 10, 2026 — Presence of Foreign Substance (Graviti Pharmaceuticals Private Limited) · FDA recall D-0293-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 73542-102-25
Product NDC 73542-102
11-digit billing NDC 73542010225
RxCUI 1719286, 1719290, 1719291
UNII 7LXU5N7ZO5
Application # ANDA203428
SPL Set ID e5880bf4-5037-4813-b7cc-656a6832ecb5
Established class (EPC) Loop Diuretic
Physiologic effect Increased Diuresis at Loop of Henle
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-06-16
Route INTRAVENOUS
Dosage form INJECTION
Substance FUROSEMIDE
TE code (Orange Book) AP · RLD · RS
Quick answers
  • RxCUI (RxNorm): 1719286
Why two NDCs? The FDA registers this code as 73542-102-25 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 73542-0102-25. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Loop Diuretic class.

Pharmacologic class Loop Diuretic
Drug family (ATC) Sulfonamides, plain
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Furosemide injection is used to treat edema (excess fluid held in body tissues) caused by various medical problems in persons who cannot take medications by mouth or in emergency situations. Furosemide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It helps your body get rid of extra fluid. It is used for swelling from heart failure, liver cirrhosis and kidney disease. In adults, oral forms can also treat high blood pressure.
  • Tablets and oral solution are swallowed, usually once or twice a day, or on certain days of the week if your doctor says so. Injected forms are for short-term use and are switched...
  • Dizziness, stomach upset, headache and more frequent urination can happen. Call your doctor right away for ringing in the ears, hearing loss, fainting, severe weakness, little urin...
  • What side effects are normal, and what should I call about?
📖 Read our full Furosemide guide →
9
Nutrient depletion considerations

Furosemide may be associated with lower levels of 9 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Furosemide nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.3524 $8.81 / 25 vials
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
73542-0102-25 You're viewing this Main listing 25 VIAL in 1 CARTON / 4 mL in 1 VIAL 2025-06-16 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Furosemide 10 mg/mL 31722-0310-32 Camber 25 vials $0.253 AP Availability likely —
Furosemide 10 mg/mL 36000-0283-25 Baxter 25 vials $0.253 AP Availability likely —
Furosemide 40 mg/4mL 55150-0323-25 Eugia 25 vials $0.253 AP Availability likely —
Furosemide 10 mg/mL 72572-0190-25 Civica, 25 vials $0.253 AP Availability likely —
Furosemide 10 mg/mL 72603-0251-25 NorthStar 25 vials $0.253 AP Availability likely —
Furosemide 10 mg/mL 73043-0023-01 Devatis 25 vials $0.253 AP Availability likely —
Furosemide 10 mg/mL 00409-6102-02 Hospira, 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 23155-0473-41 Heritage 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 25021-0311-02 Sagent 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 25021-0320-02 Sagent 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 63323-0280-02 Fresenius 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 71288-0203-03 Meitheal 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 83634-0302-02 Avenacy 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 72603-0133-25 NorthStar 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 36000-0282-25 Baxter 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 31722-0309-32 Camber 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 73043-0022-01 Devatis 25 vials $0.490 AP Availability likely —
Furosemide 10 mg/mL 00143-9156-10 Hikma 10 vials — AP FDA listed —
Furosemide 10 mg/mL 00404-9863-04 Henry 1 vial — AP FDA listed —
Furosemide 10 mg/mL 16729-0501-43 Accord 10 vials — AP FDA listed —
Furosemide 10 mg/mL 36000-0064-05 Baxter 5 vials — AP FDA listed —
Furosemide 40 mg/4mL 42571-0437-66 Micro 25 vials — AP FDA listed —
Furosemide 10 mg/mL 51662-1336-01 HF 4 ml — AP FDA listed —
Furosemide 10 mg/mL 51662-1574-01 HF 4 ml — AP FDA listed —
Furosemide 10 mg/mL 55154-2365-05 Cardinal 5 vials — AP Discontinued —
Furosemide 10 mg/mL 55154-4452-05 Cardinal 5 vials — AP FDA listed —
Furosemide 10 mg/mL 55154-9582-05 Cardinal 5 vials — AP FDA listed —
Furosemide 10 mg/mL 68083-0433-05 Gland 5 vials — AP FDA listed —
Furosemide 40 mg/4mL 70121-1164-05 Amneal 25 vials — — FDA listed —
Furosemide 10 mg/mL 70518-4444-00 REMEDYREPACK 25 vials — AP FDA listed —
Furosemide 10 mg/mL 70756-0619-05 Lifestar 5 vials — AP FDA listed —
Furosemide 10 mg/mL 71872-7127-01 Medical 1 vial — AP FDA listed —
Furosemide 10 mg/mL 71872-7278-01 Medical 1 vial — AP FDA listed —
Furosemide 10 mg/mL 71872-7314-01 Medical 1 vial — AP FDA listed —
Furosemide 10 mg/mL 72572-0275-10 Civica, 10 vials — AP FDA listed —
Furosemide 10 mg/mLthis 73542-0102-25 Maiva 25 vials — AP FDA listed —
Furosemide 10 mg/mL 84549-0251-25 ProPharma 4 ml — AP FDA listed —
Furosemide 10 mg/mL 70756-0618-05 Lifestar 5 vials — AP FDA listed —
Furosemide 10 mg/mL 70756-0620-10 Lifestar 10 vials — AP FDA listed —
Furosemide 10 mg/mL 71872-7059-01 Medical 1 vial — AP FDA listed —
Furosemide 10 mg/mL 71872-7295-01 Medical 1 vial — AP FDA listed —
Furosemide 10 mg/mL 36000-0284-25 Baxter 25 vials — AP FDA listed —
Furosemide 10 mg/mL 00404-9862-10 Henry 1 vial — AP FDA listed —
Furosemide 10 mg/mL 31722-0311-31 Camber 25 vials — AP FDA listed —
Furosemide 10 mg/mL 71872-7308-01 Medical 1 vial — AP FDA listed —
Furosemide 10 mg/mL 73043-0024-01 Devatis 25 vials — AP FDA listed —
Furosemide 10 mg/mL 73542-0103-25 Maiva 25 vials — AP FDA listed —
Furosemide 10 mg/mL 36000-0063-05 Baxter 5 vials — AP FDA listed —
Furosemide 10 mg/mL 72603-0474-25 NorthStar 25 vials — AP FDA listed —
Furosemide 10 mg/mL 84549-0474-25 ProPharma 10 ml — AP FDA listed —
Furosemide 10 mg/mL 36000-0065-05 Baxter 5 vials — AP FDA listed —
Furosemide 10 mg/mL 73542-0101-25 Maiva 25 vials — AP FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Jun 2025
📍
2026
Currently FDA-listed
1 year listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII QTT17582CB
    A strong acid used to adjust and maintain the proper pH level in liquid medicines, ensuring stability and preventing breakdown of active ingredients.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

4 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMaiva Pharma Private Limited
Application holderAVET LIFESCIENCES LTD
FDA applicationANDA203428 (ANDA)
Labeler code73542
First marketedJun 2025
Product typeHuman Prescription Drug
Portfolio3 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
⚠️ Warnings 📄 Package Label / Principal Display Panel
⚠️ Warnings 46 words ▾

WARNINGS Furosemide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required and dose and dose schedule must be adjusted to the individual patient's needs. (See DOSAGE AND ADMINISTRATION.)

📄 Package Label / Principal Display Panel 153 words ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 73542- 101- 01 Furosemide Injection, USP 20 mg/2 mL (10 mglmL) FOR IV OR IM USE Rx only 2 mL Single-Dose vial NDC 73542- 101 -25 Furosemide Injection, USP 20 mg/2 mL (10 mglmL) FOR IV OR IM USE Rx only 25 Single-Dose vial vial-label-2ml carton-label-2ml

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 73542- 102 -02 Furosemide Injection, USP 40 mg/4 mL (10 mglmL) FOR IV OR IM USE Rx only 4 mL Single-Dose vial NDC 73542- 102 -25 Furosemide Injection, USP 40 mg/4 mL (10 mglmL) FOR IV OR IM USE Rx only 25 Single-Dose via vial-label-4ml carton-label-4ml

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 73542- 103 -03 Furosemide Injection, USP 100 mg/10 mL (10 mglmL) FOR IV OR IM USE Rx only 10 mL Single-Dose vial NDC 73542- 103 -25 Furosemide Injection, USP 100 mg/10 mL (10 mglmL) FOR IV OR IM USE Rx only 25 Single-Dose vial vial-label-10ml carton-label-10ml

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Furosemide — the program that covers self-administered drugs. 22 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Furosemide. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$31.03M
Claims incl. refills
5.6M
Beneficiaries
3.6M
Spend / beneficiary
$8.60
Spend / claim
$5.52
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Maiva Pharma Private Limited. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Maiva Pharma Private Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 73542-0101-25 · Maiva 73542-0103-25 · Maiva →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.